Key facts
- This page summarizes Charles E. Sheedy's Form 4 filing for Nuo Therapeutics, Inc. (AURX).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 01 Aug 2025, 18:03.
Charles E. Sheedy - 30 Jul 2025 Form 4 Insider Report for Nuo Therapeutics, Inc. (AURX)
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- AURX
- Reported as of
- 30 Jul 2025
- Net transaction value
- +$200,000
- SEC form
- 4
- Accepted by SEC
- 01 Aug 2025, 18:03:29 UTC
- Prior SEC filing
- 19 Sep 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Charles E. Sheedy
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Charles E. Sheedy filed Form 4 for Nuo Therapeutics, Inc. (AURX) on 01 Aug 2025.
Change
- Previous filing in this sequence was filed on 19 Sep 2024.
- Current net transaction value: +$200,000.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001005483
Primary reporting owner
SHEEDY CHARLES E
- Relationship
- 10%+ Owner
- Address
- 6003 PINE FOREST, HOUSTION
- Signature
- /s/ Charles E. Sheedy
- Signature date
- 01 Aug 2025
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
AURX
transaction
Common Stock
Purchase
- Transaction value
- $200,000
- Shares
- +133,333
- Change %
- +1.2%
- Price
- $1.50
- Shares after
- 11,570,833
- Date
- 30 Jul 2025
- Ownership
- Direct
AURX
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 3,365
- Date
- 30 Jul 2025
- Ownership
- Shares held in separate trusts for the benefit of children of the Reporting Person
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
The Reporting Person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein.